Alexandre J. Guy

Pessac-sur-dordogne, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

The Reply.

The Reply.

Journal: The American journal of medicine

Published: May 21, 2026

Autoimmunity and peginterferon therapy for polycythemia vera.

Autoimmunity and peginterferon therapy for polycythemia vera.

Journal: HemaSphere

Published: March 27, 2026

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Journal: Leukemia

Published: August 20, 2025

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Journal: Leukemia

Published: August 20, 2025

Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target.

Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target.

Journal: Cell stem cell

Published: August 04, 2025

TRAKJAK: a complete blood count-based prediction of polycythemia vera at initial erythrocytosis workup to reduce financial and ecological costs.

TRAKJAK: a complete blood count-based prediction of polycythemia vera at initial erythrocytosis workup to reduce financial and ecological costs.

Journal: The American journal of medicine

Published: June 25, 2025

A single JAK2-V617F hematopoietic stem cell can initiate myeloproliferative neoplasm when transplanted into non-conditioned recipient mice.

A single JAK2-V617F hematopoietic stem cell can initiate myeloproliferative neoplasm when transplanted into non-conditioned recipient mice.

Journal: HemaSphere

Published: June 09, 2025

Mapping of Mycobacterial Enzymes Involved in Triacylglycerol Accumulation as Intrabacterial Lipid Inclusions Using Activity-Based Multitarget Inhibitor Probes.

Mapping of Mycobacterial Enzymes Involved in Triacylglycerol Accumulation as Intrabacterial Lipid Inclusions Using Activity-Based Multitarget Inhibitor Probes.

Journal: ACS infectious diseases

Published: May 29, 2025

The vinyl-α-substituted cyclopentyl oxylipins.

The vinyl-α-substituted cyclopentyl oxylipins.

Journal: Biochimie

Published: March 10, 2025

Corrigendum to "An update of isoprostanoid nomenclature" [Progress in Lipid Research 96 (2024) 101301-101310].

Corrigendum to "An update of isoprostanoid nomenclature" [Progress in Lipid Research 96 (2024) 101301-101310].

Journal: Progress in lipid research

Published: February 04, 2025

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets.

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets.

Journal: Journal of visualized experiments : JoVE

Published: December 13, 2024

The polyamino-isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi-target inhibitors against the ESKAPEE bacterium Enterobacter cloacae.

The polyamino-isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi-target inhibitors against the ESKAPEE bacterium Enterobacter cloacae.

Journal: mLife

Published: September 30, 2024

Showing 1-12 of 84

Last Updated: 09/26/2026